Corriente Advisors as of Sept. 30, 2020
Portfolio Holdings for Corriente Advisors
Corriente Advisors holds 16 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Maxar Technologies | 24.9 | $49M | 2.0M | 24.94 | |
| Reata Pharmaceuticals Cl A | 14.8 | $29M | 300k | 97.42 | |
| Cue Biopharma (CUE) | 11.0 | $22M | 1.4M | 15.05 | |
| Aptose Biosciences Com New | 10.4 | $21M | 3.4M | 6.00 | |
| Tff Pharmaceuticals | 9.9 | $20M | 1.1M | 18.47 | |
| Cardiff Oncology (CRDF) | 6.5 | $13M | 910k | 14.19 | |
| Replimune Group (REPL) | 6.0 | $12M | 513k | 23.02 | |
| Beyond Meat (BYND) | 2.9 | $5.8M | 35k | 166.06 | |
| Virgin Galactic Holdings Inc virgin galactic holdings (SPCE) | 2.4 | $4.8M | 250k | 19.23 | |
| Village Farms International (VFF) | 2.2 | $4.3M | 943k | 4.58 | |
| Datadog Cl A Com (DDOG) | 2.1 | $4.1M | 40k | 102.15 | |
| Axovant Gene The | 2.1 | $4.0M | 875k | 4.62 | |
| Roku Com Cl A (ROKU) | 1.9 | $3.8M | 20k | 188.80 | |
| Diamedica Therapeutics Com New (DMAC) | 1.6 | $3.1M | 730k | 4.24 | |
| Auryn Resources Restricted Stock | 1.1 | $2.3M | 1.5M | 1.50 | |
| Chimerix (CMRX) | 0.1 | $122k | 49k | 2.49 |
